Overview NPI-002 Intravitreal Implant for the Delay of Cataract Progression Status: Not yet recruiting Trial end date: 2022-09-01 Target enrollment: Participant gender: Summary This study will examine the safety and efficacy NPI-002 intravitreal implants post vitrectomy. Phase: Phase 1/Phase 2 Details Lead Sponsor: Nacuity Pharmaceuticals, Inc.